AKAP 3 Double Nickase Plasmid (h): sc-408185-NIC
- Target species: human
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- AKAP 3 Double Nickase Plasmid (h) consists of a pair of plasmids each encoding a D10A mutated Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed to knockout gene expression with greater specificity than its CRISPR/Cas9 KO counterpart
- Paired gRNA sequences are offset by approximately 20 bp to allow for specific Cas9-mediated double nicking of the genomic DNA, which mimics a DSB
- One plasmid in the pair contains a puromycin-resistance gene for selection; the other plasmid in the pair contains a GFP marker to visually confirm transfection
- AKAP 3 Double Nickase Plasmid (h) and AKAP 3 Double Nickase Plasmid (h2) encode distinct paired gRNA designs targeting AKAP3. One or both designs may be available
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
AKAP 3 Double Nickase Plasmid (h) | sc-408185-NIC | 20 µg | $410.00 | |||
AKAP 3 Double Nickase Plasmid (h2) | sc-408185-NIC-2 | 20 µg | $410.00 |
AKAP3 (A-kinase anchoring protein 3) is a human scaffold protein that tethers cAMP-dependent protein kinase A (PKA) and associated signaling enzymes to defined subcellular domains, supporting spatially restricted phosphorylation events. It is best known for roles in sperm cell biology, where anchoring of PKA and related effectors contributes to flagellar function, motility, and capacitation-associated signaling. By organizing localized cAMP/PKA signaling microdomains, AKAP3 influences phosphorylation-dependent regulation of cytoskeletal and membrane-associated processes. Altered expression or mislocalization of AKAP family scaffolds has been linked to dysregulated signaling in reproductive disorders and other contexts where compartmentalized kinase signaling is critical.
AKAP 3 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the AKAP3 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within AKAP3. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt AKAP3 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of AKAP3-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.